Business Context and Reporting Period
Company: Medallion Financial Corp.
Filing Type: Form 8-K (Current Report)
Date of Report: April 28, 2026
Event: Entry into a Material Definitive Agreement for a private placement of senior notes.
Key Financial Metrics
This filing reports a specific financing transaction rather than periodic financial performance metrics (e.g., revenue, profit, or cash flow). The filing text does not provide a clear value for operating results, margins, or existing liquidity levels.
| Metric | Value |
|---|---|
| Debt Issued (Principal) | $75.0 million |
| Instrument Type | 8.25% Senior Notes due 2031 |
| Interest Rate | 8.25% fixed per year |
| Maturity Date | May 1, 2031 |
| First Interest Payment | November 1, 2026 |
| Use of Proceeds | General corporate purposes |
Material Changes
The Company has increased its indebtedness by $75.0 million through the issuance of unsecured and unsubordinated obligations. These new notes rank pari passu with existing and future unsecured indebtedness. No other material changes to operations or prior period financials are disclosed in this report.
Outlook, Risks, and Management Commentary
- Management Commentary: The Company utilized a private placement exempt from registration under the Securities Act of 1933. Proceeds are designated for general corporate purposes.
- Risks/Contingencies: The filing does not explicitly detail new risks beyond the standard obligations of the new debt instrument. The Notes are unsecured, meaning they are not backed by specific collateral.
- Unusual Items: None reported.
Investor Verification Checklist
- Verify the total outstanding debt load of Medallion Financial Corp. post-issuance to assess leverage ratios.
- Confirm the specific allocation of the $75.0 million proceeds under "general corporate purposes" in future filings.
- Review the full Note Purchase Agreement (Exhibit 4.1) for covenants, prepayment penalties, or default triggers.
- Assess the impact of the 8.25% interest rate on future interest expense relative to current market rates.